Prophylactic and therapeutic treatment with the flavonone sakuranetin ameliorates LPS-induced acute lung injury
- 1 February 2017
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 312 (2) , L217-L230
Abstract
Sakuranetin is the main isolate flavonoid from Baccharis retusa (Asteraceae) leaves and exhibits anti-inflammatory and antioxidative activities. Acute respiratory distress syndrome is an acute failure of the respiratory system for which effective treatment is urgently necessary. This study investigated the preventive and therapeutic effects of sakuranetin on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. Animals were treated with intranasal sakuranetin 30 min before or 6 h after instillation of LPS. Twenty-four hours after ALI was induced, lung function, inflammation, macrophages population markers, collagen fiber deposition, the extent of oxidative stress, and the expression of matrix metalloprotease-9 (MMP-9), tissue inhibitor of MMP-9 (TIMP-1) and NF-κB were evaluated. The animals began to show lung alterations 6 h after LPS instillation, and these changes persisted until 24 h after LPS administration. Preventive and therapeutic treatment with sakuranetin reduced the neutrophils in the peripheral blood and in the bronchial alveolar lavage. Sakuranetin treatment also reduced macrophage populations, particularly that of M1-like macrophages. In addition, sakurnaetin treatment reduced keratinocyte-derived chemokines (IL-8 homolog) and NF-κB levels, collagen fiber formation, MMM-9 and TIMP-1-positive cells, and oxidative stress in lung tissues compared with LPS animals treated with vehicle. Finally, sakuranetin treatment also reduced total protein, and the levels of TNF-α and IL-1β in the lung. This study shows that sakuranetin prevented and reduced pulmonary inflammation induced by LPS. Because sakuranetin modulates oxidative stress, the NF-κB pathway, and lung function, it may constitute a novel therapeutic candidate to prevent and treat ALI.Keywords
Funding Information
- Sao Paulo Research Foundation (FAPESP) (2013/02881-4, 2014/25689-4)
- Sao Paulo Research Foundation (FAPESP) (2008/55359-5, 2014/25689-4)
- Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (National Council for Scientific and Technological Development) (471224/2009-0, 476877/2012-1, 304465/2012-7)
This publication has 65 references indexed in Scilit:
- Licochalcone A Inhibits Lipopolysaccharide-Induced Inflammatory Response in Vitro and in VivoJournal of Agricultural and Food Chemistry, 2012
- Inducible Nitric Oxide Synthase Inhibition Attenuates Physical Stress-Induced Lung Hyper-Responsiveness and Oxidative Stress in Animals with Lung InflammationNeuroimmunomodulation, 2012
- Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver InjuryFrontiers in Physiology, 2012
- Acute Respiratory Distress Syndrome: A Clinical ReviewPulmonary Circulation, 2011
- Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissueCritical Care, 2011
- Alternative Activation of Macrophages: Mechanism and FunctionsImmunity, 2010
- Isolation of an antileishmanial and antitrypanosomal flavanone from the leaves of Baccharis retusa DC. (Asteraceae)Parasitology Research, 2010
- Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-induced Epithelial Barrier Disruption and Lung InjuryJournal of Biological Chemistry, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injuryJournal of Leukocyte Biology, 2008